Wolfgang Miesbach: Platelet Variation and How Do They Move Over Time?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”Platelet variation and how do they move over time?
That may be the main diagnostic criterion for ITP – not simply how low the platelet count is at a single time point.
At the recent EHA‑SWG Scientific Meeting on Bleeding and Platelet Disorders, John Semple gave a fantastic presentation highlighting the Platelet Variability Index (PVI):
ITP cases showed highly variable platelet curves with repeated peaks and deep troughs over weeks.
Non‑ITP thrombocytopenia (splenomegaly, MDS, cirrhosis) showed flat, almost straight platelet lines with little day‑to‑day or week‑to‑week change.
Mechanistically, this striking variability in ITP may reflect a dynamic interplay between autoantibody‑mediated platelet destruction, fluctuating megakaryocyte activity and TPO-receptor signalling, creating an unstable system in which small triggers can cause big swings.
We do not fully understand this yet, but it opens an exciting window into ITP biology and suggests that platelet trajectories over time may be as informative as the absolute platelet count itself.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia
-
Sep 3, 2026, 15:42Manuel De Jesus: Innovating Anemia Monitoring Through Biomedical Engineering and Digital Technology
-
Sep 3, 2026, 15:37Hadis Nabipoor: QICL2026 Highlights the Critical Importance of Transfusion Safety
-
Sep 3, 2026, 15:32Gopal Patidar: The ISBT Haemovigilance Working Party Sharing Knowledge and Promoting Best Practices
-
Sep 3, 2026, 15:24Bhalchandra Kawdikar: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 15:18Massimo Martino: Redefining Allogeneic Transplantation in Myelofibrosis
-
Sep 3, 2026, 15:10Tvisha Subhasish: Extravascular Factor IX Beyond the Circulation
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?